GB0625374D0 - Heart and skeletal muscle inflammation (HSMI) virus - Google Patents

Heart and skeletal muscle inflammation (HSMI) virus

Info

Publication number
GB0625374D0
GB0625374D0 GB0625374A GB0625374A GB0625374D0 GB 0625374 D0 GB0625374 D0 GB 0625374D0 GB 0625374 A GB0625374 A GB 0625374A GB 0625374 A GB0625374 A GB 0625374A GB 0625374 D0 GB0625374 D0 GB 0625374D0
Authority
GB
United Kingdom
Prior art keywords
hsmi
virus
heart
skeletal muscle
muscle inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0625374A
Other versions
GB2429711B (en
GB2429711A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaq AS
Original Assignee
Pharmaq AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20042454A external-priority patent/NO20042454D0/en
Application filed by Pharmaq AS filed Critical Pharmaq AS
Publication of GB0625374D0 publication Critical patent/GB0625374D0/en
Publication of GB2429711A publication Critical patent/GB2429711A/en
Application granted granted Critical
Publication of GB2429711B publication Critical patent/GB2429711B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12064—Methods of inactivation or attenuation by serial passage
GB0625374A 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (HSMI) virus Active GB2429711B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20042454A NO20042454D0 (en) 2004-06-11 2004-06-11 Novel fish virus
US57882104P 2004-06-14 2004-06-14
PCT/NO2005/000197 WO2005121325A1 (en) 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (hsmi) virus

Publications (3)

Publication Number Publication Date
GB0625374D0 true GB0625374D0 (en) 2007-01-31
GB2429711A GB2429711A (en) 2007-03-07
GB2429711B GB2429711B (en) 2008-05-21

Family

ID=34993270

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625374A Active GB2429711B (en) 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (HSMI) virus

Country Status (4)

Country Link
CA (1) CA2570050C (en)
GB (1) GB2429711B (en)
NO (1) NO343278B1 (en)
WO (1) WO2005121325A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562802B1 (en) 2006-02-13 2013-10-22 Life Technologies Corporation Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems
CL2008001910A1 (en) * 2007-06-28 2009-08-07 Pharmaq As Fish virus with accession number ecacc 07032902; Cellphone line; vaccine and foods that comprise it; method to isolate and produce the virus, useful to prepare a medicine to prevent and / or treat cardiomyopathy syndrome in fish.
NO20081040L (en) * 2008-02-27 2009-08-28 Thia Medica As Reduced HSMI mortality
JP2013506672A (en) * 2009-10-02 2013-02-28 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク Fish reovirus immunogenic composition
NO2640832T3 (en) 2010-11-15 2018-05-19
AU2014314140B2 (en) * 2013-08-30 2020-10-22 Pharmaq As Method for propagating a virus
CA3158539A1 (en) 2019-12-16 2021-06-24 Johanna Jacoba Elisabeth Bijlsma Inactivated piscine orthoreovirus vaccine

Also Published As

Publication number Publication date
WO2005121325A1 (en) 2005-12-22
GB2429711B (en) 2008-05-21
GB2429711A (en) 2007-03-07
CA2570050C (en) 2013-03-05
CA2570050A1 (en) 2005-12-22
NO20065765L (en) 2007-01-11
NO343278B1 (en) 2019-01-14

Similar Documents

Publication Publication Date Title
ZA200709266B (en) Human GLP-1 mimetibodies, compositions, methods and uses
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL164944A0 (en) Artificial muscle
EP1805319A4 (en) Recombinant human t2 rnase and uses thereof
HK1075423A1 (en) Human nosecock
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
GB2429711B (en) Heart and skeletal muscle inflammation (HSMI) virus
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
IL163876A0 (en) Therapeutic methods and compositions involving isovlav-3-ene and isoflavan structures
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
IL181300A0 (en) Photosensitizer formulations and uses thereof
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
ZA200608999B (en) Human GLP-1 mimetibodies, compositions, methods and uses
EP1812032A4 (en) Tissue factor composition and methods
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
GB2412585B (en) Muscle treatment
GB0327676D0 (en) Temporary heart
GB0418877D0 (en) Heart
TW579871U (en) Structure of crank-type dumbbell
IL158054A0 (en) Combined bingo-based and trivia-based game
GB0426456D0 (en) Wrist pacer
GB0414260D0 (en) Form and function fillings
GB0403582D0 (en) Improvements relating to impact-resistant structures and assemblies

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130815 AND 20130821